1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Pacific Hospital Supply Co., Ltd.

Pacific Hospital Supply Co., Ltd.

TTPEX:4126
76.10
TWD
-0.70
(-0.91%)
5.95EPS
13.43P/E
5.83BMarket Cap
Nov 11Next Earn
Pacific Hospital Supply Co., Ltd.
TPEX:4126
(Taipei Exchange)

Recent

price

76.10

P/E

ratio

13.43

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TWD
15.02
18.51
19.82
19.89
20.75
22.34
23.27
23.9
25.1
28.11
29.91
27.81
30.1
31.96
32.3
33.14
33.33
Revenue per Share
4.14
4.45
4.34
4.43
4.5
4.84
4.58
3.27
2.98
6.32
4.53
5.32
4.56
5.8
6.17
5.27
5.98
Basic EPS, GAAP
2.44
3.85
5.1
3.9
1.16
-0.69
-7.21
1.96
0.68
3.39
6.74
3.93
5.43
8.55
6.29
6.35
6.51
Free Cash Flow per Basic Share
- -
2.23
2.48
3.64
2.27
2.27
2.27
2.27
2.27
2.91
3.64
4.2
4.5
4.2
4.8
5
- -
Dividend per Share
18.58
20.5
22.32
23.18
25.38
27.85
30.17
31.14
31.83
35.15
36.01
37.27
37.42
39.03
40.53
40.87
39.35
Book Value per Share
18.51
20.15
22.01
22.92
25.13
27.7
30.06
30.96
31.69
35.02
35.92
37.21
37.34
38.96
40.44
40.78
39.23
Tangible Book Value per Share
83
73
73
73
73
73
73
73
73
73
73
73
73
73
73
73
73
Basic Weighted Avg Shares
1,248
1,344
1,439
1,444
1,507
1,622
1,690
1,735
1,822
2,041
2,172
2,019
2,185
2,320
2,345
2,406
2,420
Sales/Revenue/Turnover
28.93
26.63
26.92
24.81
23.9
24.7
24.04
17.65
13.92
17.02
20.3
15.52
16.22
21.46
20.88
19.67
19.48
Operating Margin (%)
45
51
53
56
61
67
74
117
151
170
170
160
148
143
142
139
139
Depreciation Expense
344
323
315
322
327
351
333
237
216
459
329
386
331
421
448
383
434
Net Income, GAAP
6.34
15.68
14.59
14.51
16.69
16.76
19.78
22.62
20.6
13.35
22.23
10.97
19.85
19.92
19.57
19.65
19.23
Effective Tax Rate (%)
27.55
24.06
21.9
22.29
21.7
21.66
19.69
13.67
11.87
22.5
15.14
19.14
15.17
18.14
19.1
15.91
17.94
Profit Margin (%)
590
734
881
900
818
747
249
223
360
811
839
941
822
1,043
1,238
1,300
1,221
Working Capital
- -
- -
- -
- -
- -
205
335
641
606
881
777
660
424
419
418
417
416
LT Debt
1,349
1,488
1,620
1,683
1,843
2,022
2,190
2,260
2,311
2,552
2,614
2,705
2,717
2,834
2,942
2,967
2,856
Total Equity
26.53
20.54
20.54
18.18
16.53
15.88
12.44
7.96
6.64
9.14
9.74
8.08
8.61
12.18
11.65
11.07
11.6
Return on Invested Capital (%)
27.2
22.21
20.01
19.44
18.35
17.1
13
8.26
7.49
14.5
9.72
11.51
10.31
13.24
13.64
11.44
13.59
Return on Capital (%)
28.14
22.79
20.28
19.49
18.55
18.18
15.8
10.65
9.47
18.88
12.73
14.53
12.22
15.16
15.51
12.96
15.51
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
16
16
14
LT Borrowings
- -
- -
- -
LT Finance Leases
417
415
416
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
73
73
73
Market Capitalization
6,186
5,757
5,830

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,823
1,903
2,124
Cash, Cash Equivalents & STI
1,163
1,229
1,388
Accounts Receivable, Net
216
243
238
Inventories
385
364
427
Total Current Liabilities
522
477
904
Payables & Accruals
- -
- -
- -
ST Debt
16
16
14
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.95%
2.58%
0.86%
Free Cash Flow
128.34%
5.71%
1.02%
Net Income, GAAP
6.32%
4.44%
-14.51%
Sales/Revenue/Turnover
4.14%
2.21%
2.59%
Total Cash Common Dividend
- -
6.88%
4.17%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
564
563
579
639
2,345
2025
605
566
659
576
2,406
2026
582
603
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.48
1.38
1.82
1.49
6.17
2025
1.83
0.44
1.8
1.21
5.27
2026
1.44
1.53
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
4.8
2025
- -
- -
- -
- -
5
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Pacific Hospital Supply Co., Ltd. (4126.TWO) manufactures and distributes a wide range of medical and healthcare products, including disposable medical supplies, surgical instruments, hospital furniture, diagnostic equipment, and infection control products; the company offers branded lines such as wound dressings, syringes, gloves, masks, IV sets, and sterilization pouches tailored for hospitals, clinics, and long-term care facilities. Founded in 1976 and headquartered in Taoyuan, Taiwan, it operates primarily in the Asia-Pacific region, with distribution networks across Taiwan, China, Southeast Asia, and export markets in North America and Europe, serving healthcare providers, government institutions, and pharmaceutical distributors. The company segments its business into medical consumables, equipment leasing, and OEM manufacturing services for international partners. In recent developments, Pacific Hospital Supply expanded its product portfolio through the launch of advanced antimicrobial wound care solutions and eco-friendly disposable products in 2024, aligning with global sustainability trends in healthcare. It formed strategic partnerships with Japanese medical technology firms for joint ventures in high-tech diagnostic imaging equipment distribution in 2025, enhancing its competitive edge in precision medicine. Additionally, the company completed a NT$500 million funding round in late 2024 to support factory automation upgrades and market entry into Vietnam and Indonesia, marking significant operational expansions within the past year.